The Risk of Intracranial Hemorrhage after Thrombolytic Therapy with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke in Prasat Neurological Institute
Risk factors for intracerebral hemorrhage after treatment with recombinant tissue-type plasminogen activator for acute ischemic stroke
มหาวิทยาลัยขอนแก่น พ.ศ. 2558
Factors Associated with Symptomatic Intracerebral Hemorrhage after Thrombolytic Therapy in Acute Ischemic Stroke
พ.ศ. 2558
A Study of Effectiveness of Low Dose versus Standard Dose Intravenous Recombinant Tissue-type Plasminogen Activator in Acute Ischemic Stroke in Phramongkutklao Hospital
Intravenous recombinant tissue plasminogen activator (rt-PA) for acute ischemic stroke in Northeastern of Thailand
มหาวิทยาลัยขอนแก่น พ.ศ. 2558
Evaluation of the efficacy of recombinant tissue plasminogen activators in improving clinical status of acute ischemic stroke: A randomized clinical trial in Iran
พ.ศ. 2561
Trend in recombinant tissue plasminogen activator (rtPA) use for ischemic stroke in Thailand: Geographic inequality, cost of treatment and impact on 30-day case fatality rate